+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Haemophilia Treatment Market, By Type (Haemophilia A, Haemophilia B, Haemophilia C), By Product (Recombinant Coagulation Factor Concentrates, Desmopressin, Others), By Treatment, By Therapy, By Region, Competition Forecast & Opportunities, 2026

  • PDF Icon

    Report

  • 119 Pages
  • October 2021
  • Region: Global
  • TechSci Research
  • ID: 5450277
UP TO OFF until Dec 31st 2022
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Haemophilia Treatment Market was valued at USD13906.45 million in 2020 and is forecast to reach USD24205.39 million in 2026 by registering a CAGR of 9.06% during the forecast period. The Global Haemophilia Treatment Market is driven by increasing awareness campaigns regarding haemophilia among the population across the globe. Moreover, ongoing attempts in research and development activities for the development of new therapy solutions is positively impacting the growth of the market. Also, surging incidences of bleeding disorders have been observed worldwide, which is further expected to bolster the growth of market over the next few years.





The Global Haemophilia Treatment Market is segmented based on type, product, treatment, therapy, company and region. Based on type, the market can be categorized into Haemophilia A, Haemophilia B and Haemophilia C. Generally, the classification depends on the deficiency of coagulation factor present in a patient. Based on that, type A is the most frequent type, and the prevalence rate has been recorded to be four times more than haemophilia type B. In addition to this, majority of existing products are used for treating type A haemophilia, which is contributing to the increasing growth of the segment over the coming years.



Regionally, the market is segregated into North America, Europe, Asia- Pacific, South America and Middle East and Africa. Out of which, North America dominated the Global Haemophilia Treatment Market in 2020 owing to increased prevalence of haemophilia A & B in the United States and Canada. Besides this, organic and inorganic strategies of major pharmaceutical companies present in the United States is further contributing to the market growth in the region. Additionally, Asia Pacific region is expected to grow at the fastest rate in the coming years. This high growth can be ascribed to the ease of regulatory policies in Australia and Japan for the approval of drugs for the treatment of haemophilia A. In addition to this, improved funding by public and private players for the improvisation of healthcare facilities in India and China, is further anticipated the drive the market growth in Asia Pacific.



Major players operating in the Global Haemophilia Treatment Market include Novo Nordisk A/S, F. Hoffmann-La Roche AG, Bayer AG, Pfizer, Inc., Takeda Pharmaceutical Company, Sanofi S.A., CSL Behring LLC, BioMarin Pharmaceutical Inc., Octapharma AG, Sangamo Therapeutics Inc., Eagle Pharmaceuticals Inc., Baxter International, Inc., Grifols SA, Biogen Idec, Inc., Alnylam Pharmaceuticals Inc., and others. The companies are adopting new strategies in order to stay competitive in the market. Rising competitiveness is anticipated to drive innovation in the market, therefore helping the industry to solve existing challenges and meet the unmet needs in the market. Besides, these major market players are focusing on new product development, mergers and acquisitions, and business expansion to attain a higher market share.



Years considered for this report:

  • Historical Years: 2016-2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022-2026

Objective of the Study:

  • To analyze the historical growth in the market size of the Global Haemophilia Treatment Market from 2016 to 2020.
  • To estimate and forecast the market size of the Global Haemophilia Treatment Market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast the Global Haemophilia Treatment Market based on type, product, treatment, therapy, company and regional distribution.
  • To identify dominant region or segment in the Global Haemophilia Treatment Market.
  • To identify drivers and challenges for the Global Haemophilia Treatment Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Haemophilia Treatment Market.
  • To conduct pricing analysis for the Global Haemophilia Treatment Market.
  • To identify and analyze the profile of leading players operating in the Global Haemophilia Treatment Market.
  • To identify key sustainable strategies adopted by market players in the Global Haemophilia Treatment Market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of companies across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the manufacturers which could not be identified due to the limitations of secondary research. The publisher analyzed the hospitals/labs and presence of all major players across the globe.



The publisher calculated the market size of the Global Haemophilia Treatment Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.



Key Target Audience:

  • Haemophilia treatment facilities, companies and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to haemophilia treatment
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.



Report Scope:


In this report, the Global Haemophilia Treatment Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:



Global Haemophilia Treatment Market, By Type:

  • Haemophilia A
  • Haemophilia B
  • Haemophilia C

Global Haemophilia Treatment Market, By Product:

  • Recombinant Coagulation Factor Concentrates
  • Plasma Derived Coagulation Factor Concentrate
  • Desmopressin
  • Antifibrinolytics Agents

Global Haemophilia Treatment Market, By Treatment:

  • On-demand
  • Prophylaxis

Global Haemophilia Treatment Market, By End-user:

  • Replacement Therapy
  • ITI therapy
  • Gene Therapy

Global Haemophilia Treatment Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Asia-Pacific
  • India
  • China
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa

Competitive Landscape


Company Profiles: Detailed analysis of the major companies present in the Global Haemophilia Treatment Market.



Available Customizations:


With the given market data, the publisher offers customizations according to a company’s specific needs.


Frequently Asked Questions about the Global Haemophilia Treatment Market

What is the estimated value of the Global Haemophilia Treatment Market?

The Global Haemophilia Treatment Market was estimated to be valued at $10249.32 Million in 2016.

What is the growth rate of the Global Haemophilia Treatment Market?

The growth rate of the Global Haemophilia Treatment Market is 9.0%, with an estimated value of $24205.39 Million by 2026.

What is the forecasted size of the Global Haemophilia Treatment Market?

The Global Haemophilia Treatment Market is estimated to be worth $24205.39 Million by 2026.

Who are the key companies in the Global Haemophilia Treatment Market?

Key companies in the Global Haemophilia Treatment Market include Novo Nordisk A/S, F. Hoffmann, La Roche AG, Bayer AG, Pfizer, Inc., Takeda Pharmaceutical Company, Sanofi S.A., CSL Behring LLC and Octapharma AG.

Table of Contents

1. Product Overview2. Research Methodology3. Impact of COVID-19 on Global Haemophilia Treatment Market4. Executive Summary
5. Voice of Customer
5.1. Brand Awareness
5.2. Unmet Needs & Challenges
5.3. Factors Influencing Drug Purchase
6. Global Haemophilia Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Haemophilia A, Haemophilia B, Haemophilia C)
6.2.2. By Product (Recombinant Coagulation Factor Concentrates, Plasma Derived Coagulation Factor Concentrate, Desmopressin, Antifibrinolytics Agents)
6.2.3. By Treatment (On-demand and Prophylaxis)
6.2.4. By Therapy (Replacement Therapy, ITI Therapy and Gene Therapy)
6.2.5. By Company (2020)
6.2.6. By Region
6.3. Product Market Map
7. North America Haemophilia Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Product
7.2.3. By Treatment
7.2.4. By Therapy
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Haemophilia Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Product
7.3.1.2.3. By Treatment
7.3.1.2.4. By Therapy
7.3.2. Canada Haemophilia Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Product
7.3.2.2.3. By Treatment
7.3.2.2.4. By Therapy
7.3.3. Mexico Haemophilia Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Product
7.3.3.2.3. By Treatment
7.3.3.2.4. By Therapy
8. Europe Haemophilia Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Product
8.2.3. By Treatment
8.2.4. By Therapy
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Haemophilia Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Product
8.3.1.2.3. By Treatment
8.3.1.2.4. By Therapy
8.3.2. United Kingdom Haemophilia Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Product
8.3.2.2.3. By Treatment
8.3.2.2.4. By Therapy
8.3.3. France Haemophilia Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Product
8.3.3.2.3. By Treatment
8.3.3.2.4. By Therapy
8.3.4. Italy Haemophilia Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Product
8.3.4.2.3. By Treatment
8.3.4.2.4. By Therapy
8.3.5. Spain Haemophilia Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Product
8.3.5.2.3. By Treatment
8.3.5.2.4. By Therapy
9. Asia-Pacific Haemophilia Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Product
9.2.3. By Treatment
9.2.4. By Therapy
9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. India Haemophilia Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Product
9.3.1.2.3. By Treatment
9.3.1.2.4. By Therapy
9.3.2. China Haemophilia Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Product
9.3.2.2.3. By Treatment
9.3.2.2.4. By Therapy
9.3.3. Japan Haemophilia Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Product
9.3.3.2.3. By Treatment
9.3.3.2.4. By Therapy
9.3.4. Australia Haemophilia Treatment Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Type
9.3.4.2.2. By Product
9.3.4.2.3. By Treatment
9.3.4.2.4. By Therapy
9.3.5. South Korea Haemophilia Treatment Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Type
9.3.5.2.2. By Product
9.3.5.2.3. By Treatment
9.3.5.2.4. By Therapy
10. South America Haemophilia Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Product
10.2.3. By Treatment
10.2.4. By Therapy
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Haemophilia Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Product
10.3.1.2.3. By Treatment
10.3.1.2.4. By Therapy
10.3.2. Argentina Haemophilia Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Product
10.3.2.2.3. By Treatment
10.3.2.2.4. By Therapy
10.3.3. Colombia Haemophilia Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Product
10.3.3.2.3. By Treatment
10.3.3.2.4. By Therapy
11. Middle East and Africa Haemophilia Treatment Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Type
11.2.2. By Product
11.2.3. By Treatment
11.2.4. By Therapy
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. Saudi Arabia Haemophilia Treatment Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Type
11.3.1.2.2. By Product
11.3.1.2.3. By Treatment
11.3.1.2.4. By Therapy
11.3.2. UAE Haemophilia Treatment Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Type
11.3.2.2.2. By Product
11.3.2.2.3. By Treatment
11.3.2.2.4. By Therapy
11.3.3. South Africa Haemophilia Treatment Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Type
11.3.3.2.2. By Product
11.3.3.2.3. By Treatment
11.3.3.2.4. By Therapy
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Novo Nordisk A/S
14.2. F. Hoffmann-La Roche AG
14.3. Bayer AG
14.4. Pfizer, Inc.
14.5. Takeda Pharmaceutical Company
14.6. Sanofi S.A.
14.7. CSL Behring LLC
14.8. BioMarin Pharmaceutical Inc.
14.9. Octapharma AG
14.10. Sangamo Therapeutics Inc.
14.11. Eagle Pharmaceuticals Inc.
14.12. Baxter International, Inc.
14.13. Grifols SA
14.14. Biogen Idec, Inc.
14.15. Alnylam Pharmaceuticals Inc.
15. Strategic Recommendations16. About the Publisher & Disclaimer

List of Figures

Figure 1: Global Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 2: Global Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 3: Global Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 4: Global Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 5: Global Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 6: Global Haemophilia Treatment Market Share, By Company, 2020
Figure 7: Global Haemophilia Treatment Market Share, By Region, By Value, 2016-2026F
Figure 8: Global Haemophilia Treatment Product Market Map, By Value, 2016-2026F
Figure 9: North America Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 10: North America Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 11: North America Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 12: North America Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 13: North America Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 14: North America Haemophilia Treatment Market Share, By Country, By Value, 2016-2026F
Figure 15: United States Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 16: United States Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 17: United States Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 18: United States Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 19: United States Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 20: Canada Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 21: Canada Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 22: Canada Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 23: Canada Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 24: Canada Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 25: Mexico Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 26: Mexico Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 27: Mexico Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 28: Mexico Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 29: Mexico Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 30: Europe Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 31: Europe Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 32: Europe Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 33: Europe Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 34: Europe Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 35: Europe Haemophilia Treatment Market Share, By Country, By Value, 2016-2026F
Figure 36: Germany Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 37: Germany Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 38: Germany Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 39: Germany Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 40: Germany Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 41: United Kingdom Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 42: United Kingdom Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 43: United Kingdom Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 44: United Kingdom Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 45: United Kingdom Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 46: France Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 47: France Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 48: France Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 49: France Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 50: France Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 51: Italy Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 52: Italy Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 53: Italy Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 54: Italy Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 55: Italy Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 56: Spain Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 57: Spain Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 58: Spain Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 59: Spain Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 60: Spain Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 61: Asia Pacific Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 62: Asia Pacific Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 63: Asia Pacific Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 64: Asia Pacific Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 65: Asia Pacific Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 66: Asia Pacific Haemophilia Treatment Market Share, By Country, By Value, 2016-2026F
Figure 67: India Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 68: India Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 69: India Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 70: India Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 71: India Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 72: China Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 73: China Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 74: China Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 75: China Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 76: China Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 77: Japan Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 78: Japan Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 79: Japan Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 80: Japan Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 81: Japan Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 82: Australia Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 83: Australia Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 84: Australia Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 85: Australia Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 86: Australia Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 87: South Korea Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 88: South Korea Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 89: South Korea Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 90: South Korea Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 91: South Korea Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 92: South America Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 93: South America Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 94: South America Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 95: South America Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 96: South America Haemophilia Treatment Market Share, By Country, By Value, 2016-2026F
Figure 97: Brazil Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 98: Brazil Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 99: Brazil Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 100: Brazil Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 101: Brazil Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 102: Argentina Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 103: Argentina Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 104: Argentina Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 105: Argentina Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 106: Argentina Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 107: Colombia Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 108: Colombia Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 109: Colombia Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 110: Colombia Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 111: Colombia Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 112: Middle East & Africa Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 113: Middle East & Africa Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 114: Middle East & Africa Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 115: Middle East & Africa Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 116: Middle East & Africa Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 117: Middle East & Africa Haemophilia Treatment Market Share, By Country, By Value, 2016-2026F
Figure 118: Saudi Arabia Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 119: Saudi Arabia Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 120: Saudi Arabia Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 121: Saudi Arabia Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 122: Saudi Arabia Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 123: UAE Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 124: UAE Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 125: UAE Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 126: UAE Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 127: UAE Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F
Figure 128: South Africa Haemophilia Treatment Market Size, By Value (USD Million), 2016-2026F
Figure 129: South Africa Haemophilia Treatment Market Share, By Type, By Value, 2016-2026F
Figure 130: South Africa Haemophilia Treatment Market Share, By Product, By Value, 2016-2026F
Figure 131: South Africa Haemophilia Treatment Market Share, By Treatment, By Value, 2016-2026F
Figure 132: South Africa Haemophilia Treatment Market Share, By Therapy, By Value, 2016-2026F

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Novo Nordisk A/S
  • F. Hoffmann-La Roche AG
  • Bayer AG
  • Pfizer, Inc.
  • Takeda Pharmaceutical Company
  • Sanofi S.A.
  • CSL Behring LLC
  • BioMarin Pharmaceutical Inc.
  • Octapharma AG
  • Sangamo Therapeutics Inc.
  • Eagle Pharmaceuticals Inc.
  • Baxter International, Inc.
  • Grifols SA
  • Biogen Idec, Inc.
  • Alnylam Pharmaceuticals Inc.